Partnering to Optimize the CAR T-CELL THERAPY JOURNEY

partnering to optimize the car t-cell therapy journey

Please join to learn about CAR T-cell therapy.

Moderated by: Daniel Schrum, Pharm D, BCOP

Date and Time: March 12, 2026 at 6:00pm

Location: Maggiano's Little Italy, 5333 Wisconsin Avenue Northwest, Washington, DC 20015

RSVP: Diana Zolfaghari, diana.zolfaghari@gilead.com,  Phone: 202-641-1027

Objective:

• Review unmet needs in relapsed or refractory hematologic malignancies and the role of CART T-cell therapy
• Discuss the importance of timely patient identification and referrals
• Identify potential barriers to CAR T-cell therapy and considerations to overcome nonclinical  barriers
• Provide clarity on the roles of the primary oncology and cell therapy teams in the CAR T-cell therapy process